'Biomarker Summit Europe 2013', Berlin, Germany
9 October 2013 - 9 October 2013
Germany
The 'Biomarker Summit Europe 2013' will be held from 9 to 10 October 2013 in Berlin, Germany.
The role of biomarkers has become increasingly important in guiding decisions related to drug development and clinical trials. Advancements in biomarker research have led to better indications on how drug therapies affect certain patient-populations, thus giving rise to patient safety.
This conference will focus on the challenges and opportunities involved in biomarker research, from drug discovery to diagnostics. Presentations span across multiple disciplines and cover topics such as biomarker safety and efficacy, identification strategies, health economics and biomarkers in drug development.
The summit will bring together experts from the fields of pharma, biotech and academia to address the latest developments in the biomarker arena through a series of workshops and tutorials.For further information, please visit:
http://www.gtcbio.com/conference/biomarkers-europe-summit-overview(opens in new window)
The role of biomarkers has become increasingly important in guiding decisions related to drug development and clinical trials. Advancements in biomarker research have led to better indications on how drug therapies affect certain patient-populations, thus giving rise to patient safety.
This conference will focus on the challenges and opportunities involved in biomarker research, from drug discovery to diagnostics. Presentations span across multiple disciplines and cover topics such as biomarker safety and efficacy, identification strategies, health economics and biomarkers in drug development.
The summit will bring together experts from the fields of pharma, biotech and academia to address the latest developments in the biomarker arena through a series of workshops and tutorials.For further information, please visit:
http://www.gtcbio.com/conference/biomarkers-europe-summit-overview(opens in new window)